POZ - News : PEP in High Demand Following Risky Sex
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » November 2007

Web Exclusives

Fight Club: Reflections on Mexico City

More Than Medicine?

AIDSmeds in Mexico: Notes From the XVII International AIDS Conference

» More

Most Talked About

Does Undetectable Equal Uninfectious? (21)

Just Found Out? A POZ.com Guide for HIV Rookies (11)

The Blood of Christ (a powerful one-man AIDS protest) (Blog) (9)

The State of AIDS in Puerto Rico (9)

Rethinking Criminalization of HIV (8)

Life Expectancy With HIV Increases Dramatically (6)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

November 9, 2007

PEP in High Demand Following Risky Sex

People seeking post-exposure prophylaxis, or PEP—HIV medications that prevent the virus from taking hold within the body—are likely to complete the month-long regimen, say researchers at University of California Los Angeles’ AIDS Institute (eurekalert.com, 11/8).

Due to high public demand for PEP in Los Angeles county, researchers are calling for the drugs to be made widely available to people there who are engaging in high-risk sex, just as they are for those who may come in contact with HIV from accidental needle sticks in medical settings.

“We have 2,000-plus HIV infections in this county every year, and that rate has been stable for a number of years, which signifies that behavioral prevention has reached its peak,” says Steven Shoptaw of the UCLA AIDS Institute. “Having post-exposure prophylaxis available may provide another arrow in the quiver to prevent new HIV infections.”

Researchers followed 100 people who received the drug following unprotected, risky sex. Researchers followed up 26 weeks later and found that 75 percent of participants completed the treatments and that none of them had seroconverted.

emailrssprint


[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Should it be mandatory for couples to receive HIV tests before getting married?
Yes
No

Monthly Poll
Question: Is the Latino community excluded  from conversations about the domestic AIDS crisis?
Yes
No

Surveys
Tell us about your pets.

Do you use social-networking sites?

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy